Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Gunjan Chandulal Kothia has resigned from the Board of Directors of Shree Ganesh Remedies Ltd, effective September 15, 2025. The resignation is not due to any dispute or governance issue — he is transitioning internally to a new role as Head of Business Development and Innovation, designated as Senior Management Personnel. Mr. Kothia, aged 33, is a Chemical Engineering graduate with a Masters from Leeds University, UK, and brings 8 years of R&D experience and 7 years in business development of pharmaceutical intermediates. The Board approved both his exit from the directorship and his new senior management role at the same meeting held on September 15, 2025.
This is a routine internal reshuffle rather than a negative event — the director is staying with the company in a key operational role, suggesting continuity in strategy. Shareholders are unlikely to see material impact on stock price, though the loss of a board-level voice on business development matters is worth noting.